Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers Squibb

Bristol Myers Squibb receives EMA panel recommendation for approval of Opdivo with chemotherapy for lung cancer patients

Ruchika Sharma29 May 2023 11:30 AM IST

Opdivo is a programmed death-1 immune checkpoint inhibitor that is designed to uniquely harness the body's own immune system to help restore...

Gilead Sciences gets USFDA nod for new Biktarvy indication

EMA panel grants positive opinion for Remdesivir use in COVID patients with severe renal impairment, including those on dialysis: Gilead Sciences

Ruchika Sharma28 May 2023 12:00 PM IST

Foster City: Gilead Sciences, Inc. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...

AstraZeneca, Jacobio Pharma ink pact for proprietary Pan-KRAS inhibitor

AstraZeneca Ultomiris gets Japanese nod for prevention of relapses in patients with neuromyelitis optica spectrum disorder

Ruchika Sharma28 May 2023 11:00 AM IST

NMOSD is a rare and debilitating autoimmune disease that affects the central nervous system, including the spine and optic nerves.

EMA accepts marketing authorization applications for proposed biosimilar Denosumab: Sandoz

Ruchika Sharma28 May 2023 10:00 AM IST

Denosumab is a human monoclonal antibody designed to bind to the RANKL protein, an activator of osteoclasts (cells involved in breaking down bone...

Patent infringement: Factor Bioscience sues AstraZeneca, Cellectis over gene-editing technology

Patent infringement: Alnylam Pharma files new lawsuits against Pfizer, Moderna over COVID vaccines

Ruchika Sharma27 May 2023 3:18 PM IST

Alnylam is again seeking an unspecified share of royalties from the companies' vaccine sales.

Sun Pharma, Philogen complete patient enrollment in Phase III trial for Soft Tissue Sarcoma

Sun Pharma reports consolidated net profit of Rs 1984 crore in Q4

Ruchika Sharma27 May 2023 1:30 PM IST

"Several of our businesses, including specialty, India and emerging markets have continued to progress well," Sun Pharma Managing Director Dilip...

Dr Mansukh Mandaviya inaugurates 8th International Conference on Pharma and Medical Device Sector

Ruchika Sharma27 May 2023 12:31 PM IST

Dr Mandaviya unveiled the National Medical Devices Policy, 2023, and launched the Export Promotion Council for Medical Devices.

Lupin Nagpur facility completes USFDA inspection

Lupin arm gets Health Canada nod to market generic version of Spiriva for COPD

Ruchika Sharma27 May 2023 11:30 AM IST

Mumbai: Global pharma major Lupin Limited has announced that its Canada subsidiary, Lupin Pharma Canada Ltd., has received approval from Health...

Dr Agarwals Eye Hospitals merges with Davangere Nethralaya

Ruchika Sharma26 May 2023 4:54 PM IST

Dr Agarwals Eye Hospitals aims to add another 10 centers in Karnataka in the next two years.

Import Nod on Hold Over False Positives, Tissue Detection: CDSCO Panel Seeks More Data on Medtronics PTeye Device

Medtronic profit forecast hit by stronger dollar, inflation

Ruchika Sharma26 May 2023 4:18 PM IST

Dublin: Medtronic Plc on Thursday forecast annual profit below Wall Street estimates, as a strong U.S. dollar and persistently high costs of raw...

Janssen-Cilag Guselkumab receives UK nod for Crohns disease, ulcerative colitis

Janssen Milvexian gets USFDA fast track designation for Ischemic Stroke, Acute Coronary Syndrome, Atrial Fibrillation

Ruchika Sharma26 May 2023 3:15 PM IST

Raritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced that all three prospective indications for milvexian, an ...

USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas Pharma

USFDA nod to Pfizer Paxlovid for adult patients at high risk of progression to severe COVID 19

Ruchika Sharma26 May 2023 1:30 PM IST

PAXLOVID is a SARS-CoV-2 main protease (Mpro) inhibitor (also known as SARS-CoV-2 3CL protease inhibitor) therapy.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok